PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50123C00013POC ACE RAPID molecular TEST — Aptitude Medical Systems, Inc

Aptitude Medical Systems, Inc holds $14.2M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the May 14, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Aptitude Medical Systems, Inc

Recipient

May 14, 2027

PoP end

$33.8M

Obligated

541714

NAICS

AN13

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Aptitude Medical Systems, Inc — $90

Contract facts

NONE

Contract number75A50123C00013

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentAptitude Medical Systems, Inc

UEINWWEFYLD9JC3

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN13

Place of performanceOWINGS MILLS, MD

PoP end (current)May 14, 2027

PoP end (w/ options)Jul 15, 2027

Obligated$33.8M

ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND B… is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Aptitude Medical Systems, Inc. Estimated value $33.8M ($33.8M obligated). Current period of performance ends May 14, 2027 (potential Jul 15, 2027). Last award drew 1 bidder. Place of performance: OWINGS MILLS, MD.

ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND BEYOND

Recompete timing

Public

● Expiring in 250 days

Current PoP ends May 14, 2027 (250 days remaining). Agencies typically plan 12–18 months ahead — at 8.2 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Aptitude Medical Systems, Inc — $14.2M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$14.2M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50123C00013?

75A50123C00013 (POC ACE RAPID molecular TEST) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $33.8M, currently held by Aptitude Medical Systems, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50123C00013?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50123C00013 to Aptitude Medical Systems, Inc.

Who is the incumbent on 75A50123C00013?

Aptitude Medical Systems, Inc is the incumbent with $14.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends May 14, 2027.

When does Aptitude Medical Systems, Inc’s 75A50123C00013 come up for recompete?

SCOUT tracks a period-of-performance end of May 14, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50123C00013 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Feb 13, 2026